RemeGen Co. Ltd. Class H (HK:9995)
:9995
Want to see HK:9995 full AI Analyst Report?
Comparison Results
RemeGen Co. Ltd. Class H
HK$119.90
HK$70.64B
36.25
151.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$151.00
HK$123.43B
-43.30
59.05%
10 Buy
2 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$11.90
HK$9.77B
-15.87
39.89%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.75
HK$20.19B
50.10
40.15%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$27.54
HK$41.01B
-256.36
65.63%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$84.45
HK$39.97B
34.57
107.18%
6 Buy
0 Hold
0 Sell
Strong Buy
Performance Comparison
HK:9995
RemeGen Co. Ltd. Class H
97.70
60.25
160.88%
HK:9926
Akeso, Inc.
134.00
54.50
68.55%
HK:9966
Alphamab Oncology
10.03
3.63
56.72%
HK:9969
InnoCare Pharma Ltd.
13.51
3.99
41.91%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
24.48
9.98
68.83%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
73.55
39.30
114.74%